Bookbot

Pharma

Ocena książki

Parametry

  • 816 stron
  • 29 godzin czytania

Więcej o książce

"Exorbitant prices for lifesaving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in pharmaceutical companies. Now, Americans are demanding national reckoning with a monolithic industry. In Pharma, award-winning journalist and New York Times best-selling author Gerald Posner uncovers the real story of the Sacklers, the family that became one of America's wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the centure of the opioid crisis. The unexpected twists and turns of the Sakler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. Pharma reveals how and why American drug companies have put earnings ahead of patients"--

Wydanie

Zakup książki

Pharma, Gerald Posner

Język
Rok wydania
2021
Oprawa
(miękka)
Jak tylko się pojawi, wyślemy Ci wiadomość e-mail.

Metody płatności

4,2
Bardzo dobra
649 Ocena

Brakuje nam tutaj Twojej recenzji.

Tytuł
Pharma
Język
angielski
Oprawa
miękka
Liczba stron
816
ISBN10
1501152033
ISBN13
9781501152030
Seria
Ocena
4,15 z 5
Opis
"Exorbitant prices for lifesaving drugs, safety recalls affecting tens of millions of Americans, and soaring rates of addiction and overdose on prescription opioids have caused many to lose faith in pharmaceutical companies. Now, Americans are demanding national reckoning with a monolithic industry. In Pharma, award-winning journalist and New York Times best-selling author Gerald Posner uncovers the real story of the Sacklers, the family that became one of America's wealthiest from the success of OxyContin, their blockbuster narcotic painkiller at the centure of the opioid crisis. The unexpected twists and turns of the Sakler family saga are told against the startling chronicle of a powerful industry that sits at the intersection of public health and profits. Pharma reveals how and why American drug companies have put earnings ahead of patients"--